[Pulmonary arterial hypertension. Physiopathology, genetic aspects and response to the chronic use of sildenafil].
Barreto
Alessandra Costa
AC
Instituto do Coração, Hospital das Clínicas, FMUSP, São Paulo, SP.
Franchi
Sônia Meiken
SM
Pereira
Alexandre C
AC
Lopes
Antonio Augusto
AA
D004730:Endothelium, Vascular / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D010375:Pedigree; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000503:physiopathology; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000627:therapeutic use
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate